Central to both HBM4EU (European biomonitoring initiative) and NEUROSOME (neurological exposome), covering exposure biomarkers, endocrine disruptors, and chemical mixtures.
ISTITUTO UNIVERSITARIO DI STUDI SUPERIORI ( I.U.S.S.) DI PAVIA
Italian graduate school specializing in human biomonitoring, exposome science, and environmental risk assessment across health and natural hazards.
Their core work
IUSS Pavia is an advanced graduate school in Italy that specializes in environmental health research — specifically how chemical exposures and urban environments affect human health. Their core work bridges human biomonitoring (measuring pollutants in people) with exposome science (understanding the totality of environmental exposures across a lifetime). They also bring expertise in coastal hazard assessment and early warning systems, and contribute to urban health research through citizen science and living lab approaches.
What they specialise in
The exposome concept threads through HBM4EU, NEUROSOME, and URBANOME, connecting chemical exposure science with urban health and wellbeing research.
Coordinated ECFAS, a proof-of-concept for a European Copernicus Coastal Flood Awareness System, covering storm forecasting and shoreline displacement.
Participates in URBANOME, focused on urban wellbeing, living labs, participatory governance, and the link between city environments and mental/physical health.
Participates in METIS, developing methods and tools for seismic risk assessment, adding natural hazards breadth beyond coastal risks.
How they've shifted over time
IUSS Pavia's early H2020 work (2017–2019) was firmly rooted in chemical exposure science — human biomonitoring, endocrine disruptors, neurodevelopmental effects, and laboratory testing (in vitro/in vivo). From 2020 onward, their focus broadened significantly: they moved into coastal hazard systems (ECFAS), urban wellbeing through citizen science (URBANOME), and natural hazard risk methods (METIS). The shift shows a clear move from lab-based toxicology toward applied environmental risk assessment and community-engaged health research.
IUSS Pavia is expanding from molecular-level exposure science toward population-scale environmental risk assessment, with growing emphasis on citizen engagement and multi-hazard approaches.
How they like to work
IUSS Pavia primarily joins large consortia as a specialist partner rather than leading them — they coordinated only 1 of 5 projects (ECFAS, a smaller proof-of-concept). Their 158 unique partners across 33 countries indicate they integrate into broad European networks rather than working in tight, repeated clusters. This makes them an accessible, well-connected partner who brings deep scientific expertise without competing for leadership roles.
With 158 unique consortium partners spanning 33 countries, IUSS Pavia has an unusually wide network for an institution with only 5 projects — driven largely by participation in the massive HBM4EU initiative. Their reach is pan-European with no obvious geographic concentration.
What sets them apart
IUSS Pavia sits at a rare intersection: they combine deep expertise in human biomonitoring and chemical exposure science with applied environmental risk work (coastal flooding, seismic hazards, urban health). This dual competence — understanding both how environments affect human biology and how to assess environmental risks at scale — is uncommon in a single institution. For consortium builders, they offer a scientifically rigorous partner who can bridge exposure science, environmental monitoring, and community-engaged research.
Highlights from their portfolio
- HBM4EUEurope's flagship human biomonitoring initiative — IUSS contributed as a third party, placing them within the continent's largest chemical exposure research network.
- ECFASTheir only coordinated project: a proof-of-concept for a European Copernicus Coastal Flood Awareness System, showing initiative in coastal risk beyond their core health expertise.
- NEUROSOMETheir highest-funded project (EUR 516K), investigating how environmental exposures drive neurodevelopmental disorders — combining GWAS, personal sensors, and biomonitoring.